Lipoprotein Particles and Apolipoproteins

Evaluating risk for atherosclerotic cardiovascular disease

Understanding ApoB: The Key to Accurate Cholesterol and Heart Health Assessment Apolipoprotein B (ApoB) is a key structural protein found in lipoproteins that carry cholesterol and triglycerides through your bloodstream. Each atherogenic (artery-clogging) particle—such as LDL (Low-Density Lipoprotein), VLDL (Very Low-Density Lipoprotein), IDL (Intermediate-Density Lipoprotein), and Lipoprotein(a)—contains one molecule of ApoB. That means ApoB gives a direct count of the number of atherogenic particles in your blood, which is more clinically relevant than just measuring the amount of cholesterol. Why is ApoB important? While traditional cholesterol tests like LDL-C (LDL cholesterol) estimate the cholesterol content within LDL particles, ApoB actually counts the number of particles, regardless of how much cholesterol each one contains. This matters because it’s the number of ApoB-containing particles that drives plaque buildup in arteries (atherosclerosis)—not just the amount of cholesterol inside them. Studies consistently show that ApoB is a stronger predictor of cardiovascular risk than LDL-C. Elevated ApoB levels are linked to: Heart disease Stroke Peripheral artery disease Insulin resistance and metabolic syndrome What does an ApoB blood test measure? An ApoB test measures the concentration of apolipoprotein B in your blood, typically reported in mg/dL. It reflects the total number of atherogenic particles, including LDL, VLDL, IDL, and Lp(a). Reference Ranges (may vary slightly by lab): Optimal: < 90 mg/dL Borderline: 90–99 mg/dL Elevated: ≥ 100 mg/dL Some cardiology guidelines define high-risk thresholds even lower for individuals with known heart disease, diabetes, or familial hypercholesterolemia. What does a high ApoB level mean? An elevated ApoB level means there are too many cholesterol-carrying particles circulating in your blood, increasing the likelihood that they will penetrate artery walls, become oxidized, and trigger inflammation. This process leads to plaque buildup, narrowing arteries, and raising the risk of heart attacks or strokes. High ApoB can be due to: Diet high in saturated fats and refined carbs Insulin resistance or type 2 diabetes Genetic lipid disorders (e.g., familial hypercholesterolemia) Obesity or metabolic syndrome Sedentary lifestyle Poor thyroid function (hypothyroidism) What does a low ApoB level mean? A low ApoB level is generally considered favorable and associated with lower cardiovascular risk. However, extremely low levels can occur in rare genetic disorders (e.g., abetalipoproteinemia) or in cases of severe liver disease or malnutrition. ApoB vs LDL-C: Why ApoB may be better LDL-C measures cholesterol content—which can vary from particle to particle. ApoB counts each atherogenic particle, giving a more accurate picture of risk. In people with small, dense LDL particles, LDL-C may appear normal while ApoB is high—masking hidden cardiovascular risk. Guidelines from the American College of Cardiology (ACC) and European Society of Cardiology (ESC) increasingly recommend ApoB for advanced risk assessment, especially in people with: Diabetes Obesity Metabolic syndrome Borderline cholesterol profiles Who should consider ApoB testing? ApoB testing is useful for: People at intermediate or high risk of cardiovascular disease Those with normal LDL-C but a family history of heart disease Patients with metabolic syndrome or diabetes Anyone with persistently high triglycerides Individuals undergoing cholesterol-lowering treatment to assess response beyond traditional markers How to lower ApoB levels Lifestyle and medications that lower ApoB levels also reduce your cardiovascular risk: Lifestyle changes: Reduce saturated fat and trans fat intake Increase soluble fiber (from oats, legumes, fruits) Incorporate plant sterols and stanols Exercise regularly (aerobic + resistance training) Lose excess body weight Limit refined carbohydrates and sugar Medications: Statins (lower both LDL-C and ApoB) Ezetimibe PCSK9 inhibitors Bempedoic acid Niacin (less commonly used) Fibrates (especially in high triglyceride cases) Always discuss treatment options with your healthcare provider before making changes. Key Takeaways ApoB is a powerful biomarker for assessing cardiovascular risk. It reflects the number of atherogenic lipoproteins, not just cholesterol levels. Higher ApoB = more particles = greater atherosclerosis risk. It’s especially useful for people with normal LDL-C but elevated risk due to metabolic or genetic factors. ApoB can guide personalized prevention and treatment strategies. General Reference Ranges for Apolipoprotein B (ApoB) ApoB Level (mg/dL) Classification < 90 Desirable 90 – 99 Borderline High 100 – 130 High > 130 Very High ASCVD Risk-Based Therapeutic Targets for ApoB ASCVD Risk Category Recommended ApoB Target (mg/dL) Extreme Risk < 70 Very High Risk < 80 High Risk < 90 Moderate Risk < 90

correlates with risk of cardiovascular disease

A building block of LDL and other lipoproteins

Lipoprotein Subfraction Disorders: This test identifies 5 subclasses of HDL, 1 is identified as the large HDL subclass. Decreased levels of the large HDL subclass are associated with a 1.8-fold increased risk for CVD. Large HDL particles are functionally associated with an antioxidant, paraoxanase, which may help protect the arterial wall. Contributing Factors: Genetics/demographics: - Genetic predisposition - High triglyceride levels Lifestyle: - High consumption of simple carbohydrates - Overweight or obese - Sedentary lifestyle - Smoking Illness: - Insulin resistance/diabetes mellitus - Liver, kidney, and thyroid disease Drugs: - Nonselective beta blockers, androgens, progestins Treatment Considerations: Dietary/lifestyle intervention: - Avoid simple dietary carbohydrates - Fat weight loss - Regular exercise - Smoking cessation - Omega-3 fish oil Pharmacological intervention: - Nicotinic acid - Nicotinic acid plus statin Statins (minor effect) - Fibrates when triglyceride levels are elevated Disease intervention: - Correct insulin resistance - Control diabetes mellitus References: Kasper D, Fauci A, Hauser S, et al. Harrison’s Principles of Internal Medicine. 19th ed: McGraw-Hill Education. 2015. Mann DL, Zipes DP, Libby P, Bonow RO. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed: Saunders. 2015. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Saturated fatty acids and risk of coronary heart disease: Modulation by replacement nutrients. Curr Atheroscler Rep. 2010;12:384-390. Page ST, Krauss RM, Gross C, et al. Impact of mifepristone, a glucocorticoid/progesterone antagonist, on HDL cholesterol, HDL particle concentration, and HDL function.J Clin Endocrinol Metab. 2012;97:1598- 1605. Annuzzi G, Rivellese AA, Wang H, et al. Lipoprotein subfractions and dietary intake of n-3 fatty acid: The Genetics of Coronary Artery Disease in Alaska Natives study. Am J Clin Nutr. 2012;95:1315-1322.

another relevant marker of an atherogenic metabolic dysfunction

Most Protective

may be an independent protective factor against arterial stiffness.

High-density Lipoprotein Particle Number

appear to be protective in coronary artery disease

Large Very low-density lipoprotein particles

associated with an increased cardiovascular risk

measures the actual number of LDL particles

LDL particle size test — Pattern A (large) or B (small).

associated with increased risk for CVD

LDL particles vary in size, ranging from small, dense “Pattern B” particles to large, buoyant “Pattern A” particles. Smaller LDL particles are associated with an increased risk for heart disease. Small, dense LDL (“Pattern B”) is associated with insulin resistance or diabetes.

a type of potentially harmful cholesterol protein

Lipoproteins are particles that transport fats throughout the body.

A genetically determined lipoprotein and independent risk factor for cardiovascular disease.

inflammatory enzyme that circulates bound mainly to low density lipoproteins

Lipoprotein-based insulin resistance score via NMR spectroscopy.

The number of small, dense LDL particles in your blood.

Cholesterol inside VLDL, the particles that carry triglycerides.

major triglyceride-rich lipoprotein